REDS — Redsense Medical AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK59.53m
- SEK47.29m
- SEK28.18m
Annual cashflow statement for Redsense Medical AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.03 | -7.97 | -8.76 | -4.51 | 0.342 |
| Non-Cash Items | 1.68 | -2.12 | -0.03 | -1.52 | -1.02 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.51 | -2.13 | -0.995 | 0.979 | -7.55 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.84 | -12.2 | -9.78 | -5.05 | -8.23 |
| Capital Expenditures | -2.81 | -0.36 | -0.048 | -0.052 | -0.611 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -39 | -9.35 | 10.9 | 8.4 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -41.9 | -9.71 | 10.9 | 8.35 | -0.611 |
| Financing Cash Flow Items | -5.31 | — | 0.001 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 66.2 | -1.89 | -2.4 | 0 | 17.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 20.3 | -24 | -1.31 | 3.29 | 8.39 |